Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Miami Research Associates
mi
from
South Miami, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Research Centers of America, LLC
mi
from
Oakland Park, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Research Centers of America, LLC
mi
from
Oakland Park, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Medical Research Group of Central Florida
mi
from
De Bary-Orange City, FL
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
iResearch Atlanta LLC
mi
from
Decatur, GA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
IPS Research Company
mi
from
Oklahoma City, IN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
IPS Research Company
mi
from
Oklahoma City, IN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Rochester Center for Behavioral Health
mi
from
Rochester Hills, MI
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Rochester Center for Behavioral Health
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Midwest Research Group
mi
from
St. Charles, MO
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Midwest Research Group
mi
from
St. Charles, MO
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Center For Emotional Fitness
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Brooklyn Medical Institutes, LLC
mi
from
Brooklyn, NY
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Brooklyn Medical Institutes, LLC
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
NYU School of Medicine
mi
from
New York, NY
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Duke Child and Family Study Center
mi
from
Durham, NC
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Duke Child and Family Study Center
mi
from
Durham, NC
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Oregon Center for Clinical Investigations, Inc.
mi
from
Portland, OR
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Suburban Research Associates
mi
from
Media, PA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
CRI Lifetree
mi
from
Philadelphia, PA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
CRI Lifetree
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Future Search Clinical Trials, LP
mi
from
Austine, TX
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Future Search Clinical Trials, LP
mi
from
Austine, TX
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
NeuroScience, Inc.
mi
from
Herndon, VA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
NeuroScience, Inc.
mi
from
Herndon, VA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Eastside Therapeutic Resource
mi
from
Kirkland, WA
Click here to add this to my saved trials
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  7/5/2013
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Adult Attention Deficit Hyperactivity Disorder
A Randomized, Double Blind, Parallel Group, Multicenter Efficacy and Safety Study of SEP-225289 Versus Placebo in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 7/5/2013
Summit Research Network (Seattle) LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
San Diego, CA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Denver, CO
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
New Haven, CT
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Washington,
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Atlanta, GA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Anderson, IN
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Anderson, IN
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Ayer, MA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Ayer, MA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Duluth, MN
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Duluth, MN
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Bronx, NY
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Asheville, NC
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Asheville, NC
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Bismarck, ND
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Allentown, PA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Houston, TX
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Annandale, VA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Annandale, VA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Bellingham, WA
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Bellingham, WA
Click here to add this to my saved trials
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated:  7/5/2013
Clinical Research Facility
mi
from
Beloit, WI
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US
A Multicenter, Open-Label, Single-Arm Study of Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera™ (Dimethyl Fumarate) Delayed-release Capsules
Status: Enrolling
Updated: 7/5/2013
Clinical Research Facility
mi
from
Beloit, WI
Click here to add this to my saved trials
SWIFT Study in the ED
Social Work Intervention for Adults With Mild Traumatic Brain Injury: SWIFT Pilot Study
Status: Enrolling
Updated:  7/8/2013
UCSF San Francisco General Hospital and Trauma Center
mi
from
San Francisco, CA
SWIFT Study in the ED
Social Work Intervention for Adults With Mild Traumatic Brain Injury: SWIFT Pilot Study
Status: Enrolling
Updated: 7/8/2013
UCSF San Francisco General Hospital and Trauma Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
Phase IV, Double-blind, Multi-center, Randomized, Crossover Study to Compare 0.1 mmol/kg of Prohance® With 0.1 mmol/kg of Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain (TRUTH)
Status: Enrolling
Updated:  7/9/2013
Holy Name Medical Center
mi
from
Teaneck, NJ
Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain
Phase IV, Double-blind, Multi-center, Randomized, Crossover Study to Compare 0.1 mmol/kg of Prohance® With 0.1 mmol/kg of Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain (TRUTH)
Status: Enrolling
Updated: 7/9/2013
Holy Name Medical Center
mi
from
Teaneck, NJ
Click here to add this to my saved trials
A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
A Randomized Study to Assess the Efficacy of Early Physical Therapy Intervention on Upper Quarter Strength and Mobility, and Reported Upper Extremity Disability and Quality of Life Measures Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
Status: Enrolling
Updated:  7/9/2013
Mayo Clinic
mi
from
Phoenix, AZ
A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
A Randomized Study to Assess the Efficacy of Early Physical Therapy Intervention on Upper Quarter Strength and Mobility, and Reported Upper Extremity Disability and Quality of Life Measures Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
Status: Enrolling
Updated: 7/9/2013
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
A Randomized Study to Assess the Efficacy of Early Physical Therapy Intervention on Upper Quarter Strength and Mobility, and Reported Upper Extremity Disability and Quality of Life Measures Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
Status: Enrolling
Updated:  7/9/2013
Mayo Clinic
mi
from
Phoenix, AZ
A Study to Assess the Efficacy of Early Physical Therapy Intervention Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
A Randomized Study to Assess the Efficacy of Early Physical Therapy Intervention on Upper Quarter Strength and Mobility, and Reported Upper Extremity Disability and Quality of Life Measures Following a Modified Unilateral Neck Dissection for Treatment of Head and Neck Cancer
Status: Enrolling
Updated: 7/9/2013
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
An Open Label, Randomized, Four-period, Two-sequence, Fully Replicated, Single-dose, Crossover Study of the Relative Bioavailability of Two Formulations of Extended-release Divalproex Sodium Tablets in Fed Patients With Stable Epilepsy.
Status: Enrolling
Updated:  7/9/2013
Vince and Associates Clinical Research
mi
from
Overland Park, KA
A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
An Open Label, Randomized, Four-period, Two-sequence, Fully Replicated, Single-dose, Crossover Study of the Relative Bioavailability of Two Formulations of Extended-release Divalproex Sodium Tablets in Fed Patients With Stable Epilepsy.
Status: Enrolling
Updated: 7/9/2013
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
Dynamic Splinting for Plantarflexion in Spastic Hemiplegia
Dynamic Splinting for Excessive Plantarflexion in Patients With Spastic Hemiplegia: A Randomized, Controlled Study of Gait Analysis
Status: Enrolling
Updated:  7/10/2013
Medical College of Wisconsin
mi
from
Milwaukee, WI
Dynamic Splinting for Plantarflexion in Spastic Hemiplegia
Dynamic Splinting for Excessive Plantarflexion in Patients With Spastic Hemiplegia: A Randomized, Controlled Study of Gait Analysis
Status: Enrolling
Updated: 7/10/2013
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
Effects of Coenzyme Q10 (CoQ10) on Subjects With Charcot-Marie-Tooth Disease (CMT):A Double Blind, Randomized, Controlled Trial With an Open Label Follow-up Study
Status: Enrolling
Updated:  7/11/2013
John P Murtha Neuroscience and Pain Institute
mi
from
Johnstown, PA
Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease
Effects of Coenzyme Q10 (CoQ10) on Subjects With Charcot-Marie-Tooth Disease (CMT):A Double Blind, Randomized, Controlled Trial With an Open Label Follow-up Study
Status: Enrolling
Updated: 7/11/2013
John P Murtha Neuroscience and Pain Institute
mi
from
Johnstown, PA
Click here to add this to my saved trials